Clinical Trials Logo

Dissociative Disorders clinical trials

View clinical trials related to Dissociative Disorders.

Filter by:

NCT ID: NCT01422278 Active, not recruiting - Conversion Disorder Clinical Trials

Rehabilitation of Conversion Gait Disorder

Start date: September 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Evaluating the effects in functional status after three weeks of cognitive - and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

NCT ID: NCT01388140 Recruiting - Clinical trials for Dissociative Disorders

Psychopathology of Dissociative Disorders

Start date: March 2011
Phase: N/A
Study type: Observational

The goal of the project is to investigate the prevalence of dissociative disorders in psychiatric inpatients in Taiwan. Relevant clinical issues, including common psychiatric comorbidity (e.g., positive psychotic symptoms), associated psychosocial factors (e.g., negative life events, perceived parenting style), and neuro-cognitive underpinning (e.g., executive functions) were also targeted. Standardized interview schedules, self-report scales, and cognitive tasks will be applied. The investigators hypothesized that dissociative disorders would be associated with positive psychotic symptoms, a history of early interpersonal adversity, and enhanced executive functions.

NCT ID: NCT01255293 Completed - Clinical trials for Diabetic Retinopathy

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments

Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the retinal redetachment rates with 1000 centistoke versus 5000 centistoke silicone oil tamponade for repair of complex retinal detachments.

NCT ID: NCT01233908 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Diagnosis of Posttraumatic Stress Disorder Following Primary Rhegmatogenous Retinal Detachment

Start date: January 2010
Phase: N/A
Study type: Observational

To investigate the prevalence of posttraumatic stress disorder (PTSD) in patients that underwent surgery for primary rhegmatogenous retinal detachment (RRD) and to determine variables associated with the disorder. Design: Consecutive prospective observational study.

NCT ID: NCT00976222 Completed - Clinical trials for Pigment Epithelial Detachment

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Start date: December 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate the efficacy of ranibizumab in patients with retinal pigment epithelial detachment secondary to age-related macular degeneration (AMD).

NCT ID: NCT00971360 Completed - Conversion Disorder Clinical Trials

Cytokine Levels in Conversion Disorder

Start date: September 2009
Phase: N/A
Study type: Observational

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

NCT ID: NCT00841581 Completed - Clinical trials for Pigment Epithelial Detachment

Lucentis to Treat Pigment Epithelial Detachment

Start date: December 2008
Phase: Phase 2
Study type: Interventional

Patients with Pigment Epithelial Detachments secondary to Age-Related Macular Degeneration (AMD) will receive intravitreal Lucentis monthly for 6 months in the hope of improving visual acuity from a baseline evaluation.

NCT ID: NCT00835627 Completed - Depression Clinical Trials

Treatment Trial for Psychogenic Nonepileptic Seizures

NEST-T_1
Start date: September 2008
Phase: Phase 4
Study type: Interventional

The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.

NCT ID: NCT00831350 Completed - Clinical trials for Retinal Vein Occlusion

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

PADDLE
Start date: April 2009
Phase: Phase 2
Study type: Interventional

This is a study of subjects with retinal vein occlusion (RVO) specifically looking at the difference in outcomes between patients with posterior vitreous detachment (PVD) and those without PVD. Posterior vitreous detachment is a condition where the gel-like substance that occupies the space between the retina and the lens of the eye liquefies and separates from the retina. 20 subjects from Barnes Retina Institute will be enrolled in this study. Based on a pre-treatment ultrasound (a test utilizing high-frequency sound waves to look at the inside of the eye), high resolution OCT (a noninvasive procedure called optical coherence tomography to check the thickness of your retina) and clinical exam, subjects will be assigned to one of 2 groups at baseline: Group 1 will be those with PVD and Group 2 will be those without PVD. Then subjects will receive monthly intravitreal (inside the eye) injections of Ranibizumab.

NCT ID: NCT00688727 Active, not recruiting - Clinical trials for Dissociative Seizures

Cognitive Behavioural Therapy in Dissociative Seizures

Start date: March 2001
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether adults with disoociative (psychogenic non-epileptic) seizures receiving cognitive behavioural therapy (CBT) show a greater reduction in seizures and health service use and greater improvement in employment status and overall psychosocial functioning than patients who receive standard care.